Annual report
7634.TEDINET S100RAKW
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥12.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥11.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥994m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥735m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥871m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥21.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥20.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥19.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥16.8bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥15.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥14.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥13.5bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.6bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥8.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.4bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥8.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥690m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥64m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥754m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥958m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥937m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥882m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥676m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥402.98 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥358.33 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.14 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥224.88 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥263.58 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥4,931.68 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,594.54 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,289.53 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,933.55 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,769.15 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.0% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.5% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 470 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 439 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 431 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 418 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 407 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥11.8bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥10.9bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥10.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥1.2bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥990m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥971m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥890m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥681m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥815m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥19.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥18.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥17.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.2bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.3bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥13.8bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥12.8bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥11.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.3bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.4bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥350.09 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥314.16 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.41 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.51 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥246.81 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥60 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,422.06 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,123.08 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,855.53 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,565.5 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,426.84 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 72.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.3% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.2% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.6% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,420,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 334 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 313 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 305 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 288 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 289 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 104
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥9m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥64m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥151m |
| Care Welfare Relatedreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥46m |
| Care Welfare Relatedreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥15m |
| Care Welfare Relatedreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥966m |
| Care Welfare Relatedreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥966m |
| Care Welfare Relatedreportable segment | segment assets | at 2023-03-31 | ¥354m |
| Care Welfare Relatedreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥15m |
| Home Medical Treatment Relatedreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥701m |
| Home Medical Treatment Relatedreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥723m |
| Home Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.0bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.0bn |
| Home Medical Treatment Relatedreportable segment | segment assets | at 2023-03-31 | ¥2.3bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥837m |
| Medical Gas Equipment Installation Relatedreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥39m |
| Medical Gas Equipment Installation Relatedreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥6m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.7bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥87m |
| Medical Gas Equipment Installation Relatedreportable segment | segment assets | at 2023-03-31 | ¥270m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥265m |
| Medical Gas Relatedreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥446m |
| Medical Gas Relatedreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥123m |
| Medical Gas Relatedreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Medical Gas Relatedreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Medical Gas Relatedreportable segment | segment assets | at 2023-03-31 | ¥1.6bn |
| Medical Gas Relatedreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥481m |
| Nursing Homereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Nursing Homereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥20m |
| Nursing Homereportable segment | employees | at 2023-03-31 | 43 pure |
| Nursing Homereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥351m |
| Nursing Homereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥351m |
| Nursing Homereportable segment | segment assets | at 2023-03-31 | ¥1.2bn |
| Nursing Homereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥29m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥886m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥12.7bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥12.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥87m |
| —segment total | segment assets | at 2023-03-31 | ¥5.8bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥887m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥13.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥87m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥388,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥63m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥170m |
| Care Welfare Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥18m |
| Care Welfare Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥11m |
| Care Welfare Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥936m |
| Care Welfare Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥936m |
| Care Welfare Relatedreportable segment | segment assets | at 2022-03-31 | ¥336m |
| Care Welfare Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥71m |
| Home Medical Treatment Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥941m |
| Home Medical Treatment Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥710m |
| Home Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.5bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.5bn |
| Home Medical Treatment Relatedreportable segment | segment assets | at 2022-03-31 | ¥2.5bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥580m |
| Medical Gas Equipment Installation Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥17m |
| Medical Gas Equipment Installation Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥84m |
| Medical Gas Equipment Installation Relatedreportable segment | segment assets | at 2022-03-31 | ¥264m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥196m |
| Medical Gas Relatedreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥167m |
| Medical Gas Relatedreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥96m |
| Medical Gas Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Medical Gas Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Medical Gas Relatedreportable segment | segment assets | at 2022-03-31 | ¥1.4bn |
| Medical Gas Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥569m |
| Nursing Homereportable segment | capex | 2021-04-01 → 2022-03-31 | ¥235,000 |
| Nursing Homereportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥20m |
| Nursing Homereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥360m |
| Nursing Homereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥360m |
| Nursing Homereportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Nursing Homereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥10m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥839m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥11.5bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥11.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥84m |
| —segment total | segment assets | at 2022-03-31 | ¥5.8bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥840m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥12.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥84m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.6bn |
| Nursing Homereportable segment | employees | at 2023-03-31 | 43 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,505
| Item | Context | Value | Unit |
|---|---|---|---|
| Transfer of treasury stock to stock ownership plan trust | Prior1YearDuration_NonConsolidatedMember_TreasuryStockMember | 60455000 | JPY |
| Transfer of treasury stock to stock ownership plan trust | Prior1YearDuration_NonConsolidatedMember_ShareholdersEquityMember | 85172000 | JPY |
| Transfer of treasury stock to stock ownership plan trust | Prior1YearDuration_NonConsolidatedMember | 85172000 | JPY |
| Net changes of items other than shareholders equity | Prior1YearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 13407000 | JPY |
| Net changes of items other than shareholders equity | Prior1YearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember | 13407000 | JPY |
| Net changes of items other than shareholders equity | Prior1YearDuration_NonConsolidatedMember | 13407000 | JPY |
| Total changes of items during the period | Prior1YearDuration_NonConsolidatedMember_TreasuryStockMember | 60118000 | JPY |
| Total changes of items during the period | Prior1YearDuration_NonConsolidatedMember_ShareholdersEquityMember | 901072000 | JPY |
| Total changes of items during the period | Prior1YearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 13407000 | JPY |
| Total changes of items during the period | Prior1YearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember | 13407000 | JPY |
| Total changes of items during the period | Prior1YearDuration_NonConsolidatedMember | 914480000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_TreasuryStockMember | -873024000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_ShareholdersEquityMember | 12549236000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 277558000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember | 277558000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember | 12826795000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_CapitalStockMember | 436180000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember | 513708000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember | 39810000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_CapitalSurplusMember | 553518000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_LegalRetainedEarningsMember | 19810000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_GeneralReserveMember | 9590000000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | 2822752000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_RetainedEarningsMember | 12432562000 | JPY |
| Dividends from surplus | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | -186658000 | JPY |
| Dividends from surplus | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember | -186658000 | JPY |
| Provision of general reserve | CurrentYearDuration_NonConsolidatedMember_GeneralReserveMember | 800000000 | JPY |
| Provision of general reserve | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | -800000000 | JPY |
| Provision of general reserve | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember | － | JPY |
| Profit loss | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | 1089140000 | JPY |
| Profit loss | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember | 1089140000 | JPY |
| Transfer of treasury stock to stock ownership plan trust | CurrentYearDuration_NonConsolidatedMember_OtherCapitalSurplusMember | 5894000 | JPY |
| Transfer of treasury stock to stock ownership plan trust | CurrentYearDuration_NonConsolidatedMember_CapitalSurplusMember | 5894000 | JPY |
| Transfer of treasury stock to stock ownership plan trust | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember | － | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_CapitalStockMember | － | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_LegalCapitalSurplusMember | － | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_OtherCapitalSurplusMember | 5894000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_CapitalSurplusMember | 5894000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_LegalRetainedEarningsMember | － | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_GeneralReserveMember | 800000000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | 102481000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember | 902481000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_CapitalStockMember | 436180000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_LegalCapitalSurplusMember | 513708000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_OtherCapitalSurplusMember | 45704000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_CapitalSurplusMember | 559412000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_LegalRetainedEarningsMember | 19810000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_GeneralReserveMember | 10390000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | 2925234000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_RetainedEarningsMember | 13335044000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |